Fludarabine Phosphate
- Product NDC
- 42658-024
- Requested package NDC
- 42658-024-01
- 11-digit product format
- 426580024
- Labeler code
- 42658
- Product ID
- 42658-024_5b82547e-11ca-a21a-e063-6294a90a025b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fludarabine Phosphate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Hisun Pharmaceuticals USA, Inc.
- Application
- ANDA220196
- Marketing category
- ANDA
- Marketing start
- 2026-09-01
- Substance
- FLUDARABINE PHOSPHATE
- Active strength
- 25 mg/mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220196-001 | FLUDARABINE PHOSPHATE | FLUDARABINE PHOSPHATE | 50MG/2ML (25MG/ML) | INJECTABLE / INJECTION | RS | 2026-07-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A220196-001 | FLUDARABINE PHOSPHATE | 50MG/2ML (25MG/ML) | INJECTABLE / INJECTION | RS | 2026-07-23 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A220196-001 | FLUDARABINE PHOSPHATE | 50MG/2ML (25MG/ML) | INJECTABLE / INJECTION | RS | 2026-07-23 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A220196-001 | FLUDARABINE PHOSPHATE | 50MG/2ML (25MG/ML) | INJECTABLE / INJECTION | RS | 2026-07-23 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A220196-001 | FLUDARABINE PHOSPHATE | 50MG/2ML (25MG/ML) | INJECTABLE / INJECTION | RS | 2026-07-23 | caaa826d4ba7… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Fludarabine Phosphate
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| FLUDARABINE PHOSPHATE | 25 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1X9VK9O1SC | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1740865 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 291f6ee2-f5d2-ae6c-e063-6294a90a5951 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fludarabine Phosphate | FLUDARABINE PHOSPHATE | Hisun Pharmaceuticals USA, Inc. | 291f6ee2-f5d2-ae6c-e063-6294a90a5951 | 2026-09-20 | Warnings, Adverse reactions | 220196 ANDA220196 42658-024-01 42658-024 42658002401 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 42658-024-01 | 42658002401 | 1 VIAL, SINGLE-DOSE in 1 CARTON (42658-024-01) / 2 mL in 1 VIAL, SINGLE-DOSE | 2026-09-01 | No | No | Current |